These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30178833)

  • 21. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
    Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
    J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
    Herod JJ; Eliopoulos AG; Warwick J; Niedobitek G; Young LS; Kerr DJ
    Cancer Res; 1996 May; 56(9):2178-84. PubMed ID: 8616869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells.
    Xi Y; Nie X; Wang J; Gao L; Lin B
    Biomed Res Int; 2020; 2020():3607436. PubMed ID: 32309430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.
    Zhu H; Gan X; Jiang X; Diao S; Wu H; Hu J
    J Exp Clin Cancer Res; 2019 Apr; 38(1):163. PubMed ID: 30987661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
    Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
    Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
    Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.
    Chan WY; Cheung KK; Schorge JO; Huang LW; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Am J Pathol; 2000 Feb; 156(2):409-17. PubMed ID: 10666369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
    Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
    Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressions of apoptosis-associated proteins in prostate carcinoma and their clinicopathological significance].
    Zhang X; Li F; Jiang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):193-6. PubMed ID: 12515134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.
    Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Moul JW
    J Urol; 1996 Oct; 156(4):1511-6. PubMed ID: 8808919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
    Cao LQ; Chen XM; Li X
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of survivin gene and its relation with the expression of bcl-2 and bax protein in epithelial ovarian cancer].
    Zhang SL; Zhao CQ; Lin B; Li Y; Gao H
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):203-6. PubMed ID: 12885364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and significance of P53, P21WAF1 and CDK1 proteins in epithelial ovarian cancer].
    Shi HR; Zhang RT
    Ai Zheng; 2009 Aug; 28(8):882-5. PubMed ID: 19664338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.